SECTORAL ASSET MANAGEMENT INC
Filing Date
Global Rank
#5,332
/ 8,700
▲ 2293
Top Industry
Biotechnology
51.9%
Period ended 2 months ago
Filed Aug 14, 2026 · 30d
26 quarters · since Mar 2020
Portfolio Concentration
82 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026Top Position
8.3%
−3.2 pts
Top 5
26.8%
−7.0 pts
Top 10
39.7%
−9.1 pts
HHI
274
Diversified−101
Portfolio Trend
26 quarters · across all stocks
Sector Breakdown
As of Jun 30, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 93.9% | $134,545,339 |
| Unclassified | 6.1% | $8,728,653 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
17 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| IMTX | Immatics N.V. | +158,098 | 224,928 | $2,278,520 | |
| SMMT | Summit Therapeutics Inc. | +150,565 | 220,180 | $3,208,022 | |
| RCUS | Arcus Biosciences, Inc. | +65,800 | 110,870 | $3,418,122 | |
| TECX | Tectonic Therapeutic, Inc. | +51,950 | 71,009 | $2,441,289 | |
| AVBP | ArriVent BioPharma, Inc. | +49,030 | 79,043 | $2,745,953 | |
| ROIV | Roivant Sciences Ltd. | +28,600 | 61,100 | $2,162,329 | |
| DXCM | Dexcom Inc | +27,525 | 50,756 | $3,418,416 | |
| BNTX | BioNTech SE | +19,705 | 41,869 | $3,895,910 | |
| CYTK | Cytokinetics Inc | +9,030 | 16,330 | $1,391,152 | |
| COGT | Cogent Biosciences, Inc. | +4,600 | 26,740 | $1,034,838 | |
| INSM | INSMED Inc | +3,548 | 23,216 | $2,475,289 | |
| IQV | Iqvia Holdings Inc. | +2,541 | 10,848 | $2,096,050 | |
| TARS | Tarsus Pharmaceuticals, Inc. | +2,013 | 13,285 | $836,157 | |
| BSX | Boston Scientific Corp | +1,550 | 36,330 | $1,550,564 | |
| SYK | Stryker Corp | +1,255 | 7,129 | $2,244,494 | |
| PTCT | Ptc Therapeutics, Inc. | +820 | 7,470 | $609,327 | |
| ISRG | Intuitive Surgical Inc | +600 | 5,850 | $2,326,428 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
18 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| SPRY | ARS Pharmaceuticals, Inc. | −49,250 | 29,900 | $239,499 | |
| MLYS | Mineralys Therapeutics, Inc. | −17,053 | 14,565 | $392,963 | |
| SNDX | Syndax Pharmaceuticals Inc | −16,000 | 15,680 | $342,764 | |
| GPCR | Structure Therapeutics Inc. | −9,777 | 4,325 | $232,122 | |
| TRVI | Trevi Therapeutics, Inc. | −8,850 | 65,596 | $1,223,365 | |
| ABT | Abbott Laboratories | −7,498 | 18,080 | $1,640,579 | |
| GILD | Gilead Sciences, Inc. | −6,870 | 20,620 | $2,605,130 | |
| BBIO | BridgeBio Pharma, Inc. | −4,000 | 4,100 | $305,368 | |
| HNGE | Hinge Health, Inc. | −3,500 | 8,744 | $725,752 | |
| PRVA | Privia Health Group, Inc. | −3,000 | 24,136 | $621,019 | |
| EW | Edwards Lifesciences Corp | −2,512 | 14,826 | $1,341,159 | |
| UNH | Unitedhealth Group Inc | −1,722 | 13,235 | $5,500,863 | |
| VRTX | Vertex Pharmaceuticals Inc / Ma | −1,575 | 5,432 | $2,698,237 | |
| REGN | Regeneron Pharmaceuticals, Inc. | −750 | 2,169 | $1,352,458 | |
| NKTR | Nektar Therapeutics | −740 | 10,111 | $705,848 | |
| ARGX | Argenx SE | −733 | 2,831 | $2,626,516 | |
| UTHR | UNITED THERAPEUTICS Corp | −340 | 1,370 | $742,307 | |
| ASND | Ascendis Pharma A/S | −230 | 2,570 | $685,470 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
14 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| ORKA | Oruka Therapeutics, Inc. | 41,987 | $3,995,902 | |
| DFTX | Definium Therapeutics, Inc. | 78,310 | $3,683,702 | |
| IRTC | iRhythm Holdings, Inc. | 26,070 | $3,101,026 | |
| AVTX | Avalo Therapeutics, Inc. | 119,923 | $2,216,177 | |
| CBIO | Crescent Biopharma, Inc. | 121,300 | $2,183,400 | |
| PLSE | Pulse Biosciences, Inc. | 67,895 | $1,882,728 | |
| ATEC | Alphatec Holdings, Inc. | 185,900 | $1,608,035 | |
| TMDX | TransMedics Group, Inc. | 21,950 | $1,457,919 | |
| CVS | CVS HEALTH Corp | 13,000 | $1,344,850 | |
| CNC | Centene Corp | 12,000 | $770,280 | |
| HUM | Humana Inc | 1,250 | $496,525 | |
| TEM | Tempus AI, Inc. | 3,880 | $224,768 | |
| CRBP | Corbus Pharmaceuticals Holdings, Inc. | 20,000 | $187,600 | |
| ENGN | enGene Therapeutics Inc. | 21,700 | $37,541 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
9 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| EVMN | Evommune, Inc. | 589,005 | $13,541,224 | |
| RAPP | Rapport Therapeutics, Inc. | 25,421 | $795,423 | |
| BOLD | Boundless Bio, Inc. | 678,574 | $746,431 | |
| QURE | uniQure N.V. | 29,245 | $478,155 | |
| ALHC | Alignment Healthcare, Inc. | 26,911 | $474,171 | |
| RDNT | RadNet, Inc. | 7,999 | $447,064 | |
| INSP | Inspire Medical Systems, Inc. | 7,225 | $372,665 | |
| OMDA | Omada Health, Inc. | 25,620 | $322,043 | |
| NBIX | Neurocrine Biosciences Inc | 2,300 | $303,002 | |
| No positions match the current search. | ||||
82 tracked positions ·
$143,273,992 total
· filing declares
82 positions · $143,303,475
· as of Jun 30, 2026
Showing 1–50
of 82 positions by value
· page 1 of 2
| Ticker | Company | Type | Shares | Value (USD) | % of Portfolio | History |
|---|---|---|---|---|---|---|
| CTNM |
Contineum Therapeutics, Inc.
Healthcare
|
Held | 727,587 | $11,925,150 | 8.32% | |
| SI |
Shoulder Innovations, Inc.
|
Held | 430,407 | $8,728,653 | 6.09% | |
| LLY |
ELI LILLY & Co
Healthcare
|
Held | 6,354 | $7,621,178 | 5.32% | |
| UNH |
Unitedhealth Group Inc
Healthcare
|
Reduced | 13,235 | $5,500,863 | 3.84% | |
| JNJ |
Johnson & Johnson
Healthcare
|
Held | 18,218 | $4,626,825 | 3.23% | |
| ORKA |
Oruka Therapeutics, Inc.
Healthcare
|
NEW | 41,987 | $3,995,902 | 2.79% | |
| BNTX |
BioNTech SE
Healthcare
|
Added | 41,869 | $3,895,910 | 2.72% | |
| DFTX |
Definium Therapeutics, Inc.
Healthcare
|
NEW | 78,310 | $3,683,702 | 2.57% | |
| DXCM |
Dexcom Inc
Healthcare
|
Added | 50,756 | $3,418,416 | 2.39% | |
| RCUS |
Arcus Biosciences, Inc.
Healthcare
|
Added | 110,870 | $3,418,122 | 2.39% | |
| AMGN |
Amgen Inc
Healthcare
|
Held | 9,210 | $3,335,125 | 2.33% | |
| SMMT |
Summit Therapeutics Inc.
Healthcare
|
Added | 220,180 | $3,208,022 | 2.24% | |
| IRTC |
iRhythm Holdings, Inc.
Healthcare
|
NEW | 26,070 | $3,101,026 | 2.16% | |
| ABBV |
AbbVie Inc.
Healthcare
|
Held | 12,200 | $3,070,008 | 2.14% | |
| MRK |
Merck & Co., Inc.
Healthcare
|
Held | 21,480 | $2,760,180 | 1.93% | |
| AVBP |
ArriVent BioPharma, Inc.
Healthcare
|
Added | 79,043 | $2,745,953 | 1.92% | |
| VRTX |
Vertex Pharmaceuticals Inc / Ma
Healthcare
|
Reduced | 5,432 | $2,698,237 | 1.88% | |
| ARGX |
Argenx SE
Healthcare
|
Reduced | 2,831 | $2,626,516 | 1.83% | |
| GILD |
Gilead Sciences, Inc.
Healthcare
|
Reduced | 20,620 | $2,605,130 | 1.82% | |
| INSM |
INSMED Inc
Healthcare
|
Added | 23,216 | $2,475,289 | 1.73% | |
| TECX |
Tectonic Therapeutic, Inc.
Healthcare
|
Added | 71,009 | $2,441,289 | 1.70% | |
| ISRG |
Intuitive Surgical Inc
Healthcare
|
Added | 5,850 | $2,326,428 | 1.62% | |
| IMTX |
Immatics N.V.
Healthcare
|
Added | 224,928 | $2,278,520 | 1.59% | |
| SYK |
Stryker Corp
Healthcare
|
Added | 7,129 | $2,244,494 | 1.57% | |
| AVTX |
Avalo Therapeutics, Inc.
Healthcare
|
NEW | 119,923 | $2,216,177 | 1.55% | |
| CBIO |
Crescent Biopharma, Inc.
Healthcare
|
NEW | 121,300 | $2,183,400 | 1.52% | |
| ROIV |
Roivant Sciences Ltd.
Healthcare
|
Added | 61,100 | $2,162,329 | 1.51% | |
| IQV |
Iqvia Holdings Inc.
Healthcare
|
Added | 10,848 | $2,096,050 | 1.46% | |
| PLSE |
Pulse Biosciences, Inc.
Healthcare
|
NEW | 67,895 | $1,882,728 | 1.31% | |
| DHR |
Danaher Corp /De/
Healthcare
|
Held | 9,597 | $1,828,036 | 1.28% | |
| TMO |
Thermo Fisher Scientific Inc.
Healthcare
|
Held | 3,508 | $1,758,770 | 1.23% | |
| ABT |
Abbott Laboratories
Healthcare
|
Reduced | 18,080 | $1,640,579 | 1.15% | |
| ATEC |
Alphatec Holdings, Inc.
Healthcare
|
NEW | 185,900 | $1,608,035 | 1.12% | |
| BSX |
Boston Scientific Corp
Healthcare
|
Added | 36,330 | $1,550,564 | 1.08% | |
| TMDX |
TransMedics Group, Inc.
Healthcare
|
NEW | 21,950 | $1,457,919 | 1.02% | |
| CYTK |
Cytokinetics Inc
Healthcare
|
Added | 16,330 | $1,391,152 | 0.97% | |
| REGN |
Regeneron Pharmaceuticals, Inc.
Healthcare
|
Reduced | 2,169 | $1,352,458 | 0.94% | |
| CVS |
CVS HEALTH Corp
Healthcare
|
NEW | 13,000 | $1,344,850 | 0.94% | |
| EW |
Edwards Lifesciences Corp
Healthcare
|
Reduced | 14,826 | $1,341,159 | 0.94% | |
| TRVI |
Trevi Therapeutics, Inc.
Healthcare
|
Reduced | 65,596 | $1,223,365 | 0.85% | |
| BMY |
Bristol Myers Squibb Co
Healthcare
|
Held | 21,150 | $1,218,663 | 0.85% | |
| VERA |
Vera Therapeutics, Inc.
Healthcare
|
Held | 25,573 | $1,097,337 | 0.77% | |
| COGT |
Cogent Biosciences, Inc.
Healthcare
|
Added | 26,740 | $1,034,838 | 0.72% | |
| MDT |
Medtronic plc
Healthcare
|
Held | 11,100 | $868,353 | 0.61% | |
| TARS |
Tarsus Pharmaceuticals, Inc.
Healthcare
|
Added | 13,285 | $836,157 | 0.58% | |
| KURA |
Kura Oncology, Inc.
Healthcare
|
Held | 71,480 | $784,135 | 0.55% | |
| CNC |
Centene Corp
Healthcare
|
NEW | 12,000 | $770,280 | 0.54% | |
| UTHR |
UNITED THERAPEUTICS Corp
Healthcare
|
Reduced | 1,370 | $742,307 | 0.52% | |
| HNGE |
Hinge Health, Inc.
Healthcare
|
Reduced | 8,744 | $725,752 | 0.51% | |
| NKTR |
Nektar Therapeutics
Healthcare
|
Reduced | 10,111 | $705,848 | 0.49% |
Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.